February 2020
Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, et al. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020 MMWR. 2020;69(7);177–182.
Vaccination remains the best way to protect against influenza and its potentially serious complications…- Patel A, Jernigan DB, 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 MMWR. 2020;69(5)140-6.
As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments… - Oliver SE, Moore KL. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants MMWR. 2020;69(5);136-9.
This report summarizes the indications for DTaP-IPV-Hib-HepB and provides guidance for its use… - Freedman MS, Hunter P, Ault K, Kroger A. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020 MMWR. 2020;69(5);133-5.
Changes in the 2020 adult immunization schedule for persons aged ≥19 years include new or revised recommendations for hepatitis A vaccine (HepA); human papillomavirus vaccine (HPV); influenza vaccine; serogroup B meningococcal vaccine (MenB); pneumococcal vaccine; and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)… - Robinson CL, Bernstein H, Poehling K, Romero JR, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020 MMWR. 2020;69(5);130–2.
Changes in the 2020 child and adolescent immunization schedule for persons aged 18 years or younger include new or updated ACIP recommendations for hepatitis A vaccine (HepA); influenza vaccine; meningococcal B vaccine (MenB); and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)…
January 2020
- Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019 MMWR. 2020;69(3):77–83.
This report provides recommendations for the use of Td or Tdap for the decennial Td booster, tetanus prophylaxis when indicated for wound management, and catch-up immunization schedule for persons aged ≥7 years with incomplete or unknown vaccination history… - Merritt TA, Rasmussen SA, Bright MA, Roussos-Ross D, Sims SM, Gurka MJ, et al. Variation in Tdap and Influenza Vaccination Coverage Among Pregnant Women by Insurance Type — Florida, 2016–2018 MMWR. 2020;69(3);72–76.
Medicaid benefits for Tdap and influenza vaccination during pregnancy might increase vaccination coverage… - Owusu D, Hand J, Tenforde MW, Feldstein LR, DaSilva J, Barnes J, et al. Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade — Louisiana, 2019 MMWR. 2020;69(2);40-43.
Early influenza B/Victoria virus activity in Louisiana resulted in illnesses in children that were similar to typical seasonal influenza; however, some illnesses were severe, and one death was reported…
.png)
No hay comentarios:
Publicar un comentario